RJRadosław Jeleniewicz

Radosław Jeleniewicz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Radosław Jeleniewicz has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2016
      • Vol. 69  (1) , 24-6

    [Autoimmune diseases with the presence of anti-ku antibodies - analysis of three cases].

    by Ewa Wielosz, Maria Majdan, Radosław Jeleniewicz, Marcin Mazurek

    A-Ku are rare antibodies, which are reported in course of connective tissue diseases. Their prevalence ranges from 0 to 10% , 2%, on average. The main symptoms associated with the presence of a-Ku antibodies include: myositis, arthritis, Raynaud`s phenomenon and skin lesions. The above features are often defined as autoimmune clinical syndrome associated with a-Ku antibodies. In recent years, three cases with the presence of a-Ku antibodies were observed at the Department of Rheumatology and Connective Tissue Diseases. Case 1, a 77-year-old man, with the diagnosis of mixed connective tissue disease according to Raynaud`s phenomenon, myositis, arthritis and presence of a-ribonucleoprotein antibodies. Moreover, secondary Sjögren syndrome (SS) and myasthenia gravis were diagnosed. Case 2, a 56-year-old woman with longstanding history of Raynaud`s phenomenon, sclerodactyly, myositis and arthritis. Based on clinical manifestations and additional tests, systemic sclerosis and myositis were diagnosed. Case 3, a 46-year-old woman with SS diagnosis, long-standing history of Raynaud`s phenomenon, arthralgia and polyneuropathy. Moreover, HCV infection with the presence of cryoglobulin was confirmed. The presence of a-Ku antibodies in high titers was found in all cases. The clinical conditions improved after steroid and immunosuppressive therapy. In conclusion, clinical syndromes with the presence of a-Ku antibodies are associated with a wide range of non-specific symptoms, regarding muscle, joint and skin involvement, in particular. The conditions are more often diagnosed in the elderly; in the majority of cases, they are characterized by mild courses, good response to steroid therapy and good prognosis.


    • 1 January 2015
      • Vol. 68  (1) , 104-7

    [Biological treatment in severe Still's disease--a case report].

    by Dorota Suszek, Arkadiusz Koszarny, Radosław Jeleniewicz, Maria Majdan, Anna Bończak, Agnieszka Czukiewska, Barbara Koszła, Sylwia Kurlej, Justyna Markowicz, Agnieszka Szymczyk

    Still's disease and systemic juvenile idiopathic arthritis (JIA) are multisystem inflammatory diseases of unknown etiology, different disease course and prognosis. Still's disease is characterized by hectic fever, arthritis, skin rash, organomegaly, elevated serum ferritin and inflammatory factors. Early diagnosis and intensive treatment can prevent disease progression and reduce complications such as amyloidosis, physical disability. The first choice of treatment are high doses of corticosteroids and synthetic disease-modifying drugs (DMARDs), including methotrexate (MTX), cyclosporine (CsA). Biologic agents are second line therapy when DMARDs aren't effective, e.g. monoclonal antibodies blocking the action of TNF-alpha (anti-TNF-α), interleukin-1 (ANK--anakinra) and interleukin-6 (TCZ--tocilizumab). We describe in details treatment strategies applied in a young woman with severe Still's disease treated with combination therapy of DMARDs and anti-TNF-α, including etanercept (ETA) or certolizumab (CER). TCZ was applied for the treatment of Still's disease following treatment failure with anti-TNF-α. We've achieved a complete remission of the Still's disease during treatment TCZ.

  • Open Access

    Selected problems of biologic therapy in rheumatoid arthritis patients – pregnancy during therapy. Case reports

    by Radosław Jeleniewicz, Bożena Targońska-Stępniak, Ewa Wielosz, Maria Majdan

    Przygotowanie do zajścia w ciążę i jej prowadzenie u pacjentek chorych na reumatoidalne zapalenie stawów (RZS) stanowi istotny problem kliniczny. Niekorzystny wpływ na przebieg ciąży może mieć sam proces zapalny i powikłania narządowe RZS, ale również stosowane leczenie. Niewiele jest informacji dotyczących przebiegu ciąży u chorych na RZS leczonych lekami biologicznymi. W pracy opisano dwie chore na RZS, które w trakcie terapii lekami biologicznymi zaszły w ciążę.

  • Open Access

    Selected problems of biologic therapy in rheumatoid arthritis patients – inefficacy of several biologic therapies. Case reports

    by Radosław Jeleniewicz, Maria Majdan, Bożena Targońska-Stępniak, Ewa Wielosz

    Przełomem w terapii reumatoidalnego zapalenia stawów (RZS) było zastosowanie biologicznych leków modyfikujących przebieg choroby (LMPCh). Istotnym praktycznym problemem jest pierwotna lub wtórna nieskuteczność terapii biologicznych. W pracy przedstawiono dwa przypadki chorych na RZS leczonych wieloma lekami biologicznymi z powodu ich nieskuteczności.

  • Open Access

    Catastrophic antiphospholipid syndrome in a patient with systemic lupus erythematosus

    by Ewa Wielosz, Maria Majdan, Radosław Jeleniewicz, Małgorzata Biskup

    W pracy przedstawiono dwa przypadki prawdopodobnego katastroficznego zespołu antyfosfolipidowego (KZA) w przebiegu tocznia rumieniowatego układowego (TRU) poprzedzonych infekcją przewodu pokarmowego. Przypadek 1. Chory w wieku 53 lat, u którego KZA rozpoznano na podstawie zakrzepicy wielonarządowej (zatorowość płucna, zawał mięś­nia sercowego, ostra niewydolność nerek) oraz wysokiego miana wszystkich markerowych przeciwciał antyfosfolipidowych. Chory spełniał również kryteria rozpoznania TRU. Objawy chorobowe wystąpiły po infekcji przewodu pokarmowego. Przypadek 2. Chora, lat 48, z wieloletnim wywiadem TRU i ZA, której stan zdrowia pogorszył się po przebytej infekcji przewodu pokarmowego. Rozpoznano KZA na podstawie: mikrozatorowości płucnej, zakrzepicy żył układu wrotnego i żył głębokich kończyn dolnych oraz ostrej niewydolności nerek. W obu przypadkach w leczeniu zastosowano systemową antykoagulację, terapię pulsacyjną steroidami, cyklofosfamidem, wlewy immunoglobulin, uzyskując ustąpienie objawów.

    • 1 January 2011
      • Vol. 57  (3) , 28

    [Neoplasia in patients with systemic lupus erythematosus: analysis of two cases of hematological malignancies].

    by Dorota Suszek, Radosław Jeleniewicz, Maria Majdan

    Patients with systemic lupus erythematosus (SLE) demonstrate a significantly greater risk of malignant disease (MD) in comparison to the healthy population. Hematological malignancies, especially lymphomas, predominate among MD patients. It is believed that immune disturbances in SLE, lymphotropic virus superinfections, and long-term immunosuppressive therapy may induce the process of MD. Case 1. A female with a 34-year history of SLE was treated with low doses of glucocorticoids and chloroquine. In July 2011, severe pancytopenia complicated by septic shock was observed and the patient died. Histopathologic examination of bone marrow revealed the presence of a B-cell lymphoma. Case 2. A female with a 26-year history of SLE presented with anti-dsDNA and anti-SSA antibodies. Exacerbations of SLE were treated with high doses of glucocorticoids, cyclophosphamide, and azathioprine. In December 2011, pancytopenia was observed and bone marrow histology was in favor of acute monoblastic leukemia. Data from the literature and our own observations confirm the necessity of oncologic follow-up in SLE. The risk of MD in SLE increases with duration of the disease and depends on the serologic profile of SLE and medication used. Hematological exacerbations in SLE, particularly protracted and therapy-resistant anemia and leukopenia, should be differentiated from a hematological malignancy.

    • 1 July 2004
      • Vol. 112  (1)

    [Relationship between peritoneal equilibration test and surface tension of peritoneal effluent in CAPD patients].

    by Maria Majdan, Radosław Jeleniewicz, Ewa Krzyzanowska, Marek Majdan

    Surface phenomena resulting from interactions between molecules occur commonly in nature. Peritoneal effluent is a mixture of organic and inorganic substances both macro- and micromolecular. Surfactants present in dialysate affect its surface properties. Among them are: proteins, phospholipids, fatty acids. Our aim in this study was to investigate relationships between peritoneal membrane solute transport characteristics and surface tension of peritoneal effluent. The study was conducted in 40 CAPD patients who were stable, without peritonitis (24 M, 16F), age 51.5 +/- 15.8 (range 30-79) mean CAPD duration 26.4 +/- 20.6 months (range 4-72). Standard peritoneal equilibration test (sPET) was done in all patients. Dialysate surface tension (ST) values after 4 hours dewell were determined using Wilhelmy Plate method. Mean ST values of individual dialysate sample based on 10 measurements were calculated. According to the PET values patients were divided into two groups: group 1 (high/high average transporters, n = 26) and group 2 (low average/low transporters, n = 14). Patients in group 1 had significantly lower ST of dialysate than patients in group 2 (51.2 +/- 4.8 vs 57.9 +/- 1.4 mN/m), p<0.01. The lowest values of ST (48.5 +/- 5 mN/m) were found in patients classified as high transporters (n = 8). Correlation's: significant negative correlation was found between ST and D4/P4 for creatinine (r = -0.45, p<0.005) and significant positive correlation between ST and D4/DO for glucose (r = 0.48, p = 0.003). We conclude that there are significant relationships between peritoneal transport status and surface tension of peritoneal effluent. High transporters have significantly higher concentrations of surfactants in dialysis effluent.

    • 1 January 2002
      • Vol. 57  (2) , 290-5

    Changes of surface tension of dialysate depending on its composition in continuous ambulatory peritoneal dialysis.

    by Radosław Jeleniewicz, Maria Majdan, Kinga Buraczyńska, Patrycja Portala, Marek Majdan

    Surface phenomena resulting from interactions among molecules occur commonly in nature. Surfactants, substances with surface activity, have a big influence on surface tension. They reduce surface tension when added to the solution, even in minimal concentration. The behaviour of surface tension of the dialysate is difficult to properly assess, because of its complex composition. Dialysate is a mixture of organic and inorganic substances, both macro- and micromolecular. Among them are proteins, phospholipids, fatty acids. In the literature there are no publications showing the behaviour of surface tension of the dialysate. The aim of the study was the assessment of changes of dialysate surface tension in non-complicated continuous peritoneal dialysis (CAPD), depending on time of the presence of dialysis fluid in the peritoneal cavity and on the concentration of different substances in it. The study was performed on 39 dialysate samples obtained from 6 patients chronically treated with continuous ambulatory peritoneal dialysis (CAPD). During the study patients had no symptoms of peritonitis. Surface tension of the dialysate was determined, using the Wilhelmy's method. Ten measurements were performed in every sample of the dialysate and the mean values and standard deviation were calculated. Simultaneously the concentrations of sodium, glucose, urea, creatinine, total protein were measured in the dialysate. As a result of the study a significant negative correlation between dialysate protein concentration and surface tension was found. The significant negative correlation between surface tension and the dwell time was also found. There was no significant correlation between the value of surface tension of the dialysate and concentrations of glucose, urea, creatinine and sodium.